NeueHealth Stock Price, News & Analysis

NeueHealth, Inc. (formerly listed on the New York Stock Exchange under the ticker NEUE) is described in company disclosures and press releases as a value-driven healthcare company that operates within the healthcare plans and services ecosystem. According to multiple "About NeueHealth" sections in its news releases, the company is grounded in the belief that health consumers are entitled to high-quality, coordinated care. NeueHealth focuses on aligning the interests of health consumers, providers, and payors to help make healthcare accessible and affordable across the ACA Marketplace, Medicare, and Medicaid.

Company materials state that NeueHealth delivers clinical care to hundreds of thousands of health consumers through a combination of owned clinics and partnerships with more than 3,000 affiliated providers. In addition, NeueHealth reports that it enables independent providers and medical groups to participate in performance-based arrangements through a suite of technology and services that are scaled centrally and deployed locally. Across its communications, NeueHealth emphasizes a value-driven, consumer-centric care model that is intended to create a more aligned and coordinated healthcare experience and to maximize value across the healthcare system.

Business focus and care model

Based on the company’s own descriptions, NeueHealth operates in the healthcare sector with an emphasis on value-based care. Its model centers on coordinating care among consumers, payors, and providers, and on supporting providers who work under performance-based or value-based arrangements. The company highlights activity across government-related and exchange-based coverage categories, specifically the ACA Marketplace, Medicare, and Medicaid, reflecting its focus on populations served by these programs.

NeueHealth’s disclosures describe two broad areas of activity: delivering clinical care directly through owned clinics and working with a large network of affiliated providers; and offering centrally scaled technology and services that are implemented locally to support independent providers and medical groups. In its earnings releases, NeueHealth also references value-based consumers and enablement services lives as key metrics, underscoring the importance of both direct care delivery and enablement services in its operating model.

Corporate status and ownership

NeueHealth underwent a significant corporate change following an Agreement and Plan of Merger entered into on December 23, 2024. According to a Form 8-K filed on October 2, 2025, NH Holdings Acquisition 2025, Inc. merged with and into NeueHealth, Inc., with NeueHealth surviving as a wholly owned subsidiary of NH Holdings 2025, Inc. Parent and Merger Sub are described as being indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. (NEA). The same Form 8-K explains that, at the effective time of the merger, each share of NeueHealth common stock (subject to specified exceptions) was converted into the right to receive cash consideration.

In a Business Wire release dated October 2, 2025, NeueHealth announced the successful closing of this take-private transaction, stating that NeueHealth had been acquired by an affiliate of NEA at an enterprise value referenced in that release. The release further notes that certain stockholders, including NEA and other existing investors, entered into rollover agreements to continue their investments in the privately held company, and that NeueHealth’s executive leadership team also entered into rollover agreements.

Delisting and trading status of NEUE

NeueHealth’s common stock was previously listed on the New York Stock Exchange under the symbol NEUE. A Form 25 (Notification of Removal from Listing and/or Registration) filed by the New York Stock Exchange on October 2, 2025 identifies NeueHealth, Inc. as the issuer and the New York Stock Exchange LLC as the exchange, and specifies that the class of securities being removed from listing and/or registration is common stock. The October 2, 2025 press release similarly states that, with the completion of the transaction, the company’s common stock ceased trading on the New York Stock Exchange on October 2, 2025.

The October 2, 2025 Form 8-K explains that, in connection with the closing of the merger, the company notified the NYSE of its intent to remove its common stock from listing and requested that the NYSE file Form 25 to delist the common stock and deregister it under Section 12(b) of the Securities Exchange Act of 1934. The Form 8-K further states that, upon effectiveness of the Form 25, NeueHealth intends to file a Form 15 to request deregistration of its securities under Section 12(g) and suspension of its reporting obligations under Sections 13 and 15(d) of the Exchange Act. As a result, the NEUE ticker represents a formerly listed security associated with a company that continues to operate as a privately held entity.

Operations and scale indicators

In its earnings releases, NeueHealth reports serving large numbers of consumers under value-based arrangements and enablement services. For example, in its first and second quarter 2025 results releases, the company cites serving hundreds of thousands of consumers and highlights growth in value-based consumers served and enablement services lives compared with prior periods. These metrics, along with references to owned clinics and thousands of affiliated providers, indicate that NeueHealth operates at scale within its chosen segments of the healthcare market.

NeueHealth’s disclosures also emphasize its focus on government-related and exchange-based coverage (ACA Marketplace, Medicare, and Medicaid) and on value-based arrangements such as ACO REACH, as reflected in its financial reporting categories. While the detailed financial tables in the company’s releases include specific quarterly and annual figures, the structural information they provide—such as the presence of capitated revenue, ACO REACH revenue, and service revenue—supports the characterization of NeueHealth as a healthcare company engaged in value-based and performance-based care arrangements.

Position within the healthcare ecosystem

Across its public communications, NeueHealth consistently presents itself as a company working to align incentives among health consumers, providers, and payors. It highlights its role in making healthcare more coordinated and in supporting independent providers and medical groups through centrally scaled technology and services. Its activities across ACA Marketplace, Medicare, and Medicaid, and its use of value-based metrics such as value-based consumers served and enablement services lives, position it within the broader healthcare plans and value-based care landscape.

Following the completion of its take-private transaction and delisting from the NYSE, NeueHealth’s ongoing operations, as described in its press releases and SEC filings, are conducted as a privately held company under the ownership of an affiliate of NEA. Historical information about NeueHealth’s activities while it was publicly traded, including its financial reporting and risk disclosures, remains available through its past SEC filings.

Key characteristics of NeueHealth

• Sector and industry: Healthcare sector, with a focus consistent with healthcare plans and value-based care arrangements.
• Business focus: Value-driven, consumer-centric care model that aims to align the interests of consumers, providers, and payors.
• Coverage areas: Activity across ACA Marketplace, Medicare, and Medicaid, as described in company materials.
• Care delivery: Clinical care delivered through owned clinics and partnerships with a large network of affiliated providers.
• Provider enablement: Support for independent providers and medical groups through technology and services used in performance-based arrangements.
• Corporate status: Formerly a NYSE-listed company under the ticker NEUE; now a wholly owned subsidiary of an entity affiliated with New Enterprise Associates following a completed merger.